https://stock.noler.com/us/stock/reata-pharmaceuticals-inc https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/accrued-rent-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/cumulative-effect-on-retained-earnings-net-of-tax https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-subject-to-expiration https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-amount https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/income-tax-examination-interest-accrued https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/income-taxes-receivable https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/insider-transactions-other/purchases https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/insider-transactions-other/sales https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/inventory-noncurrent https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/investment-income-nonoperating https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/lease-incentive-payable-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/liabilities-noncurrent https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/license-and-services-revenue https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/litigation-settlement-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/marketable-securities-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/notes-receivable-fair-value-disclosure https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/other-sundry-liabilities-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/paid-in-capital-other https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/payments-for-proceeds-from-productive-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/payments-of-financing-costs https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-and-excess-tax-benefit-from-share-based-compensation https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/receivables-net-current https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/reimbursement-revenue https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/total-contract-liability https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/reata-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted